Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal cell membrane lipids are essential structural and functional components of the eye, particularly within the photoreceptor outer segments. These membranes are characterized by an exceptionally high concentration of long-chain polyunsaturated fatty acids (LC-PUFAs), most notably docosahexaenoic acid (DHA), which provides the high fluidity required for the rapid signaling processes of phototransduction (SanGiovanni & Chew, 2005, Progress in Retinal and Eye Research). However, this unique lipid composition, combined with high oxygen levels and constant light exposure, makes the retina highly vulnerable to oxidative stress and lipid peroxidation (Kaur et al., 2012, Journal of Lipids). The accumulation of toxic lipid-derived byproducts, such as the bisretinoid A2E, contributes significantly to the pathogenesis of Age-related Macular Degeneration (AMD) and Stargardt disease by inducing retinal pigment epithelium (RPE) degeneration (Sparrow et al., 2012, Journal of Lipid Research). Therapeutic interventions targeting these lipids include the administration of omega-3 fatty acids to support membrane integrity and the use of antioxidants or modified retinoids, such as ALK-001, to inhibit the formation of cytotoxic lipid aggregates (Alkeus Pharmaceuticals, 2023).
Maintenance of membrane fluidity and structural integrity, reduction of oxidative stress-induced lipid peroxidation, and inhibition of the formation of toxic lipofuscin components like A2E (SanGiovanni & Chew, 2005; Sparrow et al., 2012).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal cell membrane lipids.